Metraipolis › archive › dc_ee0aef437a93

Effects of Modifying Supportive Care Medications in Combination Therapy with Pertuzumab, Trastuzumab, and Taxane Anticancer Drugs — Europe PMC PMID:41283629

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41283629
DOI
10.3390/pharmacy13060168
License (as archived)
solo-consultazione
Archived
2026-11-08T12:07:52.109Z
SHA-256 of the archived text
f2b2bd3a5f179e1c2bff96eb5b06e29ecf65009cf160a1fbb6aad96d525781a9
Stable URL of this page
https://metraipolis.com/documento/dc_ee0aef437a93

How to cite

Effects of Modifying Supportive Care Medications in Combination Therapy with Pertuzumab, Trastuzumab, and Taxane Anticancer Drugs — Europe PMC PMID:41283629 — Europe PMC (en), https://europepmc.org/article/MED/41283629 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ee0aef437a93 (Metraipolis archive dc_ee0aef437a93, sha256 f2b2bd3a5f179e1c2bff96eb5b06e29ecf65009cf160a1fbb6aad96d525781a9)
BibTeX
@misc{dcee0aef437a93,
  title = {Effects of Modifying Supportive Care Medications in Combination Therapy with Pertuzumab, Trastuzumab, and Taxane Anticancer Drugs — Europe PMC PMID:41283629},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41283629},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ee0aef437a93; sha256 f2b2bd3a5f179e1c2bff96eb5b06e29ecf65009cf160a1fbb6aad96d525781a9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41283629. Agents can read the archived copy with the MCP tool read_document.